These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21044226)

  • 1. Complete clinical response to cetuximab in a patient with metastatic cutaneous squamous cell carcinoma.
    Miller K; Sherman W; Ratner D
    Dermatol Surg; 2010 Dec; 36(12):2069-74. PubMed ID: 21044226
    [No Abstract]   [Full Text] [Related]  

  • 2. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck.
    Kim S; Eleff M; Nicolaou N
    Head Neck; 2011 Feb; 33(2):286-8. PubMed ID: 19953623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases.
    Giacchero D; Barrière J; Benezery K; Guillot B; Dutriaux C; Mortier L; Lacour JP; Thyss A; Peyrade F
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):716-8. PubMed ID: 21831617
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab.
    Suen JK; Bressler L; Shord SS; Warso M; Villano JL
    Anticancer Drugs; 2007 Aug; 18(7):827-9. PubMed ID: 17581306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.
    Bauman JE; Eaton KD; Martins RG
    Arch Dermatol; 2007 Jul; 143(7):889-92. PubMed ID: 17638733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful combination therapy of a locally advanced squamous cell carcinoma of the skin with cetuximab and γ-irradiation.
    Göppner D; Nekwasil S; Franke I; Gollnick H; Leverkus M
    J Dtsch Dermatol Ges; 2010 Oct; 8(10):826-8. PubMed ID: 20731754
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin.
    Maubec E; Petrow P; Scheer-Senyarich I; Duvillard P; Lacroix L; Gelly J; Certain A; Duval X; Crickx B; Buffard V; Basset-Seguin N; Saez P; Duval-Modeste AB; Adamski H; Mansard S; Grange F; Dompmartin A; Faivre S; Mentré F; Avril MF
    J Clin Oncol; 2011 Sep; 29(25):3419-26. PubMed ID: 21810686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
    Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis.
    Marti A; Fauconneau A; Ouhabrache N; Beylot-Barry M; Pham-Ledard A
    JAMA Dermatol; 2016 Mar; 152(3):343-5. PubMed ID: 26606112
    [No Abstract]   [Full Text] [Related]  

  • 10. First Drug Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma.
    Aschenbrenner DS
    Am J Nurs; 2019 Jan; 119(1):27. PubMed ID: 30589700
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.
    Kamaria M; Shea CR; Chin RK; Cohen EE; Maggiore R; Bolotin D
    Clin Exp Dermatol; 2014 Jul; 39(5):604-7. PubMed ID: 24758726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab.
    Rubió Casadevall J; Graña-Suárez B; Hernandez-Yagüe X; Vayreda Ribera J; Huc Grasa O; Brunet Vidal J
    Eur J Dermatol; 2009; 19(2):163-5. PubMed ID: 19106040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 Inhibitor.
    Chang AL; Kim J; Luciano R; Sullivan-Chang L; Colevas AD
    JAMA Dermatol; 2016 Jan; 152(1):106-8. PubMed ID: 26422398
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
    Matsushita S; Kawai K; Tada K; Mera K; Kubo H; Ibusuki A; Yoshii N; Kanekura T
    J Dermatol; 2010 Jul; 37(7):666-70. PubMed ID: 20629834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
    Vermorken JB; Trigo J; Hitt R; Koralewski P; Diaz-Rubio E; Rolland F; Knecht R; Amellal N; Schueler A; Baselga J
    J Clin Oncol; 2007 Jun; 25(16):2171-7. PubMed ID: 17538161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous squamous cell carcinoma: current topics].
    Uhara H
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):538-41. PubMed ID: 22662361
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab.
    Leard LE; Cho BK; Jones KD; Hays SR; Tope WD; Golden JA; Hoopes CW
    J Heart Lung Transplant; 2007 Dec; 26(12):1340-4. PubMed ID: 18096489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinoma.
    Baltaci M; Fritsch P; Weber F; Tzankov A; Sögner P; Derler AM; Höpfl R
    Br J Dermatol; 2005 Jul; 153(1):234-6. PubMed ID: 16029373
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic basal cell carcinoma: report of two cases treated with cetuximab.
    Caron J; Dereure O; Kerob D; Lebbe C; Guillot B
    Br J Dermatol; 2009 Sep; 161(3):702-3. PubMed ID: 19575727
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis?
    Alexandrescu DT; Dasanu CA; Farzanmehr H; Kauffman CL
    Br J Dermatol; 2008 Dec; 159(6):1378-80. PubMed ID: 18808417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.